On 2026-06-15, enGene Therapeutics Inc (ENGN) announced earnings per share of $-0.43 for the fiscal quarter ending 2026-04-30, beating the average analyst estimate of $-0.48.
The next expected annoucement date for quarterly earnings is 2026-09-10, with an average estimated earnings per share of $-0.47 for the fiscal quarter ending 2026-07-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-06-15 | 2026-04-30 | $-0.48 | $-0.43 |
| 2026-03-09 | 2026-01-31 | $-0.55 | $-0.44 |
| 2025-12-22 | 2025-10-31 | $-0.55 | $-0.73 |
| 2025-09-11 | 2025-07-31 | $-0.49 | $-0.57 |
| 2025-06-12 | 2025-04-30 | $-0.50 | $-0.51 |
| 2025-03-10 | 2025-01-31 | $-0.37 | $-0.48 |
| 2024-12-19 | 2024-10-31 | $-0.40 | $-0.34 |
| 2024-09-10 | 2024-07-31 | $-0.38 | $-0.32 |
| 2024-06-14 | 2024-04-30 | $-0.24 | $-0.38 |
| 2024-03-11 | 2024-01-31 | -- | $0.46 |